“Analysis of Favipiravir Adverse Drug Reactions during COVID-19 Pandemic: A Retrospective Study Based on Iraqi Pharmacovigilance Center Database”, AJPS, vol. 24, no. 2, pp. 228–236, Apr. 2024, doi: 10.32947/ajps.v24i2.1069.